An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the response rate of decitabine in previously
treated and untreated Taiwanese participants with Myelodysplastic Syndrome (MDS - a disease
associated with decreased production of blood cells, blood cells are produced but do not
mature normally).